SESSION TITLE: Pulmonary Vascular Disease I
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: To describe the clinical characteristics of patients undergoing to Epoprostenol therapy for the treatment of right heart failure secondary to pulmonary hypertension.
METHODS: Retrospective cohort of patients admitted to the emergency room because of right heart failure secondary to pulmonary hypertension between jan 2011 to oct 2015. Adults older than 18 y with epoprostenol infusión during the index hospitalization where included. Data were extracted from the pulmonary hypertension registry (SHIP) of a high complexity institution in Cali, Colombia.